How do hormonal and anti-androgen therapies work for women losing hair?

Your follicles aren't dying, they're shrinking, and that difference is the whole reason this class of treatment exists. Inside a susceptible follicle, testosterone gets converted into dihydrotestosterone, which shortens the growing phase a little more with every cycle until the hair coming through is fine, short and barely pigmented. Hormonal therapy interrupts that conversation at one of three points, and which point you interrupt decides the drug, the dose and the precautions you'll live with.

• Receptor blockers: Spironolactone at 100 to 200 mg daily occupies the receptor and lowers ovarian output.
• Enzyme blockers: Finasteride at 1 to 5 mg daily stops testosterone converting into dihydrotestosterone.
• Hormone modulators: Combined pills raise binding globulin, cutting the free androgen reaching your scalp.
• Slow verdict: Nothing shows for 3 to 4 months; real assessment sits at 6 to 12.

What role do androgens actually play in female pattern hair loss?

Here's what most people get wrong: your blood test can come back completely normal and androgens can still be driving the loss. Only a proportion of affected women show measurably raised testosterone, free androgen index or DHEA sulphate, and the reported rate swings from under ten percent to well over half depending on who was studied. What actually differs is how sensitive your follicles are, and that sensitivity is local to the top of your head.

1. Local sensitivity: Frontal and vertex follicles carry more androgen receptor and more 5-alpha-reductase than occipital ones.
2. Conversion: Testosterone becomes dihydrotestosterone inside the follicle and binds the receptor in the dermal papilla.
3. Cycle shortening: Anagen drops from a normal 2 to 6 years down to months or even weeks.
4. Miniaturisation: Each cycle yields a thinner, shorter, paler shaft while more follicles sit empty between cycles.
5. Visible pattern: You see a widening central part and lost density, not the sharp receding hairline men get.

How do anti-androgen medications block androgen activity at the hair follicle?

Think of the androgen receptor as a lock sitting inside your dermal papilla cells. Dihydrotestosterone is the key that turns it and switches on the gene programme that cuts your growing phase short. An anti-androgen is a key shaped closely enough to slide into that lock without turning it, so the hormone circulating around it has nowhere to dock.

When are 5-alpha-reductase inhibitors used in women, and how well do they work?

This is the drug class where the honest answer used to be "it doesn't work in women," and that conclusion came from one dose that was probably too low. Dihydrotestosterone binds the receptor with roughly twice the affinity of testosterone and lets go about five times slower, so cutting its supply is a genuinely different lever from fighting it at the receptor. What changed the picture was raising the dose, not changing the target.

Can combined oral contraceptives or menopausal hormone therapy help with thinning hair?

Yes, but only sideways, and the progestin inside the pill decides whether you're helped or harmed. Oral oestrogen pushes your liver to make more sex hormone binding globulin, and since only free hormone can enter a follicle, a bigger bound fraction means less androgen actually reaching your scalp even if total testosterone barely moves. Some women can date the start of their thinning to the day they began a pill with the wrong progestin in it.

Which women are the right candidates for hormonal treatment, and what testing should come first?

Treating a shed with an anti-androgen wastes a year of your life, so candidacy turns first on the diagnosis being right. Pattern loss creeps in over years as a widening central part and a thinner ponytail; a shedding disorder arrives as diffuse volume loss with hair visibly coming out, traceable to a trigger 2 to 4 months back like childbirth, surgery, rapid weight loss or a new medication. The two can run together, which is exactly why the work-up comes before the prescription.

1. Confirm the pattern: Trichoscopy showing shaft calibre variation across the mid-scalp is the hallmark of miniaturisation; a positive pull test points to active shedding instead.
2. Run the baseline panel: Ferritin, full blood count, thyroid stimulating hormone and vitamin D, since iron deficiency blunts the response to any hair treatment.
3. Target the hormones: Total and free testosterone, DHEA sulphate, binding globulin, prolactin and 17-hydroxyprogesterone only when there are signs of excess, and a very high result demands imaging.
4. Fix the reproductive plan: Premenopausal means contraception is built in from the start; postmenopausal opens up the enzyme blockers without that constraint.
5. Photograph the baseline: Fixed lighting, fixed part position and a recorded part-width measure, because twelve months later a stabilised head looks like nothing happened.

What side effects and monitoring does anti-androgen therapy involve?

Almost everything you'll notice happens in the first six to eight weeks and then settles down, which is worth knowing before you quit in week three. On spironolactone that means more trips to the bathroom, light-headedness when you stand, breast tenderness and periods that go irregular. The potassium question generates the most anxiety and carries the least real risk for most women, but the exceptions are specific and you need to know if you're one of them.

• Early nuisance: Splitting the dose, taking it earlier and building up from 50 mg blunts most of it.
• Menstrual disturbance: The commonest reason women abandon the drug, and adding a combined pill fixes it.
• Potassium checks: Warranted over about 45, or with reduced kidney function, diabetes, heart failure or interacting drugs.
• Review rhythm: Three months for tolerance, then six and twelve months with photographs to judge effect.

Why does pregnancy prevention matter so much on these medications?

This isn't a legal formality on a consent form, it's developmental biology. Male genital development in the first trimester runs on androgen signalling, and a drug that blocks the receptor or stops the conversion to dihydrotestosterone crosses the placenta and interferes with it. The documented result is undervirilisation of a male fetus, ranging from hypospadias to genuinely ambiguous genitalia, and it isn't reversible after birth.

How long does hormonal treatment take to show results, and what does success look like?

Patience here isn't a virtue, it's a biological requirement. A follicle can only show you the benefit by growing a brand new shaft, and it has to finish its resting phase, re-enter growth over 2 to 4 months, then push that shaft out at roughly a centimetre a month before you can see or feel anything. Judging this at week six is like digging up a seed to check on it.

1. Months 0 to 3: Nothing visible, and a temporary shed in the first six to eight weeks is a synchronisation effect, not harm.
2. Month 6: Your first meaningful look, best judged on standardised photographs rather than impressions.
3. Month 12: The real verdict, splitting roughly into thirds: clear cosmetic gain, stabilisation with modest thickening, or continued loss needing the plan reconsidered.
4. Declaring failure: Only fair after twelve months of an adequate dose taken consistently, and the answer is usually escalation, not abandonment.

What happens when hormonal treatment is paused or stopped?

Stopping hands your follicles straight back to the conditions that were shrinking them. The drug suppresses an ongoing process rather than curing it, so androgen signalling resumes within days of your last dose, and the delay before you see it is the same lag that hid the benefit on the way in. Stop in January and you'll notice in early summer, and most women never connect the two.

• Signalling resumes: Within days of the last dose, though nothing is visible yet.
• Visible loss lags: By the same 3 to 6 months the original benefit took to appear.
• Gains are gone: Within about 12 months the scalp returns to where it would have been untreated.
• Restarting works: A second course usually recovers ground over another 6 to 12 months, slightly less completely after a long break.

How does hormonal therapy compare with topical and procedural treatments?

The comparison is usually the wrong question, because topical minoxidil and a systemic anti-androgen work through completely separate routes and the trials that have compared them show the pair beats either alone. That's why the standard opening position is both, in any woman who can take a tablet. Where the options genuinely separate is on daily effort, reproductive constraint and what they cost you over a decade.